New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Lineage Cell Therapeutics, Inc.
LCTX
Shape
US Flag

AMEX

Unprofitable

EPS improving

Unprofitable

EPS improving

159M

Biotechnology

Next Earning date - 14 Nov 2024

159M

Biotechnology

Next Earning date - 14 Nov 2024

0.84USD
Shape-0.02 ( -1.76%)
favorite-chart

Relative Strenght

5
favorite-chart

Volume Buzz

-61%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

48%

Quote Panel

Shape
Updated October 26, 2024
1W -2.93 % 1M -8.59 % 3M -17.55 % 1Y -25.58 %

Key Metrics

Shape
  • Market Cap

    158.81M


  • Shares Outstanding

    188.84M


  • Share in Float

    188.00M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    0.841


  • Average Volume

    467073


  • Beta

    1.261


  • Range

    0.77-1.61


  • Industry

    Biotechnology


  • Website

    https://www.lineagecell.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

25.67x

P/S Ratio

2.32x

P/B Ratio

0.0

Debt/Equity

-391.0%

Net Margin

$-0.1

EPS

How LCTX compares to sector?

P/E Ratio

Relative Strength

Shape

LCTX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$8M

Shape492%

2025-Revenue

$0.14

Shape-375%

2025-EPS

$8M

Shape-46%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Craig-Hallum

initialise

Previous: Not converted

2024-08-20

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.04
vs -0.05

Q4.22

arrow
arrow

N/A

-0.03
vs -0.05

Q1.23

arrow
arrow

N/A

-0.03
vs -0.04

Q2.23

arrow
arrow

N/A

-0.03
vs -0.04

Q3.23

arrow
arrow

N/A

-0.04
vs -0.04

Q4.23

arrow
arrow

N/A

-0.03
vs -0.03

Q1.24

arrow
arrow

N/A

-0.04
vs -0.03

Q2.24

arrow
arrow

N/A

-0.03
vs -0.03

Q3.24

arrow
arrow

N/A

-0.04
vs -0.04

Q4.24

arrow
arrow

N/A

-0.04
vs -0.03

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+36%

3M  vs 2.2M

Q4.22

arrow
arrow

+99%

1.9M  vs 960K

Q1.23

arrow
arrow

-54%

2.4M  vs 5.2M

Q2.23

arrow
arrow

-29%

3.2M  vs 4.6M

Q3.23

arrow
arrow

-58%

1.2M  vs 3M

Q4.23

arrow
arrow

+9%

2.1M  vs 1.9M

Q1.24

arrow
arrow

-39%

1.4M  vs 2.4M

Q2.24

arrow
arrow

-56%

1.4M  vs 3.2M

Q3.24

arrow
arrow

-17%

1M  vs 1.2M

Q4.24

arrow
arrow

-37%

1.3M  vs 2.1M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-8%

-0.08
vs -0.12

Q4.22

arrow
arrow

-9%

-0.09
vs -0.08

Q1.23

arrow
arrow

-6%

-0.06
vs -0.09

Q2.23

arrow
arrow

-7%

-0.07
vs -0.06

Q3.23

arrow
arrow

-10%

-0.10
vs -0.07

Q4.23

arrow
arrow

-8%

-0.08
vs -0.10

Q1.24

arrow
arrow

-9%

-0.09
vs -0.08

Q2.24

arrow
arrow

-8%

-0.08
vs -0.09

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

92

92
vs 87

6%

Q4.22

arrow
arrow

103

103
vs 92

12%

Q1.23

arrow
arrow

117

117
vs 103

14%

Q2.23

arrow
arrow

107

107
vs 117

-9%

Q3.23

arrow
arrow

104

104
vs 107

-3%

Q4.23

arrow
arrow

115

115
vs 104

11%

Q1.24

arrow
arrow

115

115
vs 115

NA

Q2.24

arrow
arrow

112

112
vs 115

-3%

Earnings Growth

Latest News